Improving the clinical value and utility of CGM systems: issues and recommendations A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group

Erstveröffentlichung

2017

Authors

Petrie, John R.

Peters, Anne L.

Bergenstal, Richard M.

Holl, Reinhard

Fleming, G. Alexander

et al.

Wissenschaftlicher Artikel

Published in

Diabetologia ; 60 (2017), 12. - S. 2319-2328. - ISSN 0012-186X. - eISSN 1432-0428

Link to publication

https://dx.doi.org/10.1007/s00125-017-4463-4

Faculties

Medizinische Fakultät

Institutions

Institut für Epidemiologie und Medizinische Biometrie

Subject headings

[Free subject headings]: Adverse events | Ambulatory glucose profile | CGM | Glucose | Insulin | Interstitial | Position statement | Safety | Technology | Therapy | Time in range | randomized controlled-trial | glucose-sensing technology | insulin delivery | open-label | hypoglycemia | multicenter | sensor | adults
[DDC subject group]: DDC 610 / Medicine & health

Metadata

Show full item record